Skip Navigation


Schizophrenia Bulletin Advance Access originally published online on July 27, 2005
Schizophrenia Bulletin 2005 31(4):910-921; doi:10.1093/schbul/sbi035
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
31/4/910    most recent
sbi035v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Greenwood, K. E
Right arrow Articles by Wykes, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenwood, K. E
Right arrow Articles by Wykes, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oupjournals.org.

Negative Symptoms and Specific Cognitive Impairments as Combined Targets for Improved Functional Outcome Within Cognitive Remediation Therapy

Kathryn E Greenwood
Department of Psychology, Institute of Psychiatry, De Crespigny Park, London SE5 8AF

Sabine Landau
Biostatistics and Computing, Institute of Psychiatry, London

Til Wykes
Department of Psychology, Institute of Psychiatry, De Crespigny Park, London SE5 8AF

To whom correspondence should be addressed; tel: +44 (0) 207 919 2983, fax: +44 (0) 207 919 2473, e-mail: k.greenwood{at}iop.kcl.ac.uk.

Negative symptoms and poor cognition are both associated with poor functional outcome in schizophrenia. This poor functional outcome has been attributed to poor cognition rather than any independent contribution from symptoms. Identifying target cognitive processes and mechanisms that predict community function, and possible moderator effects of negative symptoms, will allow the development of cognitive remediation programs that are successful in improving functional outcome. A referred sample of 53 in- and outpatients with schizophrenia with general cognitive impairment (including 28 with severe negative symptoms) and 22 healthy controls, balanced for premorbid IQ, were compared cross sectionally on measures of community shopping skills, executive function, and working memory. Across the groups, there were direct relationships between community functioning and specific executive functions, and there were interactions between group membership and the types of associations found. Working memory was independently associated with accurate community functioning only in people with schizophrenia and negative symptoms. This association was not due to the sole presence of working memory impairment or just to negative symptoms. Poor community function is predicted both by specific cognitive impairments that are prominent in people with negative symptoms and through the moderating effect of negative symptoms on the working memory–community function relationship. This may reflect a synergistic association between symptoms and cognition: negative symptoms arise from cognitive impairment but also impact detrimentally on working memory functioning. Both cognitive processes and negative symptoms should be targeted in cognitive remediation to effect the greatest change in community functions.

Keywords: schizophrenia / cognition / mechanisms / community function / neurocognitive / interventions


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Schizophr BullHome page
N. D. Volkow
Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
Schizophr Bull, May 1, 2009; 35(3): 469 - 472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. W. Buchanan, D. C. Javitt, S. R. Marder, N. R. Schooler, J. M. Gold, R. P. McMahon, U. Heresco-Levy, and W. T. Carpenter
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments
Am J Psychiatry, October 1, 2007; 164(10): 1593 - 1602.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
R. W. Buchanan
Persistent Negative Symptoms in Schizophrenia: An Overview
Schizophr Bull, July 1, 2007; 33(4): 1013 - 1022.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.